Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR2 | P30518 | 10/20 | 0.47 |
| ▸ | AVPR1A | P37288 | 12/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.47 |
| ▸ | OXTR | P30559 | 3/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20728257 | 0.91 | OXTR (0.57) | AVPR2AVPR1AKCNH2OXTR | |
| SCHEMBL20727970 | 0.90 | AVPR2 (0.47) | AVPR2AVPR1AKCNH2OXTR | |
| SCHEMBL20728117 | 0.90 | AVPR2 (0.46) | AVPR2AVPR1AKCNH2OXTR | |
| SCHEMBL20728115 | 0.90 | AVPR2 (0.46) | AVPR2AVPR1AKCNH2OXTR | |
| SCHEMBL20728265 | 0.88 | AVPR2 (0.62) | AVPR2AVPR1AKCNH2OXTR | |
| SCHEMBL20728280 | 0.87 | AVPR1A (0.49) | AVPR2AVPR1AKCNH2OXTR | |
| SCHEMBL20728269 | 0.86 | AVPR1A (0.53) | AVPR2AVPR1AKCNH2OXTR | |
| SCHEMBL20728500 | 0.86 | AVPR1A (0.57) | AVPR2AVPR1AKCNH2OXTR | |
| SCHEMBL20728454 | 0.85 | AVPR1A (0.46) | AVPR2AVPR1AKCNH2OXTR | |
| SCHEMBL20727943 | 0.85 | AVPR2 (0.51) | AVPR2AVPR1AKCNH2OXTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3634963-B1 | 1-(2-AZASPIRO[3.3]HEPTAN-6-YL)-5,6-DIHYDRO-4H-BENZO[F][1,2,4]TRIAZOLO[4,3-A][1,4]DIAZEPINE DERIVATIVES AS V1A RECEPTOR ANTAGONISTS FOR TREATING NEUROPSYCHOLOGICAL DISORDERS | BLACKTHORN THERAPEUTICS INC (US) | 2023-02-22 | — | — | EP | disclosed |